Organisation in WEINHEIM
STIFTUNG ELN FOUNDATION
In 0 Bekanntmachungen genannt, seit 1. Januar 2023, aber in keiner als Auftragnehmer eines Zuschlags.
Fördermittel
Kohesio und Finanztransparenzsystem der EU, so gezählt.
6 Förderungen, zusammen 976.228 €.
| Quelle | Balken | Betrag | Förderungen |
|---|---|---|---|
| EU-Haushalt (Finanztransparenzsystem) | 976.228 €6 | 6 |
| Jahr | Programm | Projekt | Betrag und Beleg |
|---|---|---|---|
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101104421 - IMPACT- AML - MASTER FRAMEWORK AND PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA | 101104421 - IMPACT- AML - MASTER FRAMEWORK AND PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA | 127.956 €Beleg: Förderung 2023/JAG.1221677.1, Empfänger 94745Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101104421 - IMPACT- AML - MASTER FRAMEWORK AND PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA | 101104421 - IMPACT- AML - MASTER FRAMEWORK AND PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA | 638.296 €Beleg: Förderung 2023/JAG.1221677.2, Empfänger 94735Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 139.989 €Beleg: Förderung 2023/JAG.1386981.1, Empfänger 87634Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 57.647 €Beleg: Förderung 2023/JAG.1386981.2, Empfänger 87649Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 5.186 €Beleg: Förderung 2023/JAG.1386981.3, Empfänger 87684Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 101136502 - RESOLVE - RESIDUAL DISEASE ASSESSMENT IN HEMATOLOGIC MALIGNANCIES TO IMPROVE PATIENT-RELEVANT OUTCOMES ACROSS EUROPE (RESOLVE) | 7.155 €Beleg: Förderung 2023/JAG.1386981.4, Empfänger 87680Mittelbindung |
Angaben aus den Bekanntmachungen
0 Nennungen seit 1. Januar 2023, zuletzt am 1. Januar 2023, dieser Organisation zugeordnet. Wie wir zuordnen
- Anschrift
- IM LANGGEWANN 45, 69469 WEINHEIM
- Schreibweisen
- STIFTUNG ELN FOUNDATION